Insider filings from the past week show a sharp split between bold buyers and heavy sellers across US markets.
The biggest buyer is SMMT Chairman and CEO Robert Duggan. He filed on June 12 that he purchased $50M worth of Summit Therapeutics shares — nearly 3.8 million shares. That's a massive bet from the top executive at the clinical-stage biotech.
At HOOD, venture firm Ribbit Capital filed a $20M buy. The VC firm holds a board seat at Robinhood Markets. The purchase covers 250,000 shares and was filed June 9.
On the sell side, Marc Andreessen has been steadily offloading IOT stock. The Samsara director filed four separate sales this week. The combined value tops $51M. Andreessen sold shares on June 8, 9, 10, and 11.
Lightspeed Venture Partners dumped over $37M in NAVN stock across three filings on June 12 and 15. The VC firm is the main shareholder in Navan, the travel management software company.
FBIN attracted activist buying. Ed Garden, the hedge fund director on the board of Fortune Brands Innovations, filed a $13M purchase on June 11. Garden bought 320,000 shares at around $40.60 each.
TJX Companies Executive Chairman Carol Meyrowitz filed a $9.1M sale in TJX on June 10. She sold roughly 55,600 shares.
This is not financial advice.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
